ES2218796T3 - Uso de un compuesto peptidico para el tratamiento del lupus erimatoso sistemico. - Google Patents

Uso de un compuesto peptidico para el tratamiento del lupus erimatoso sistemico.

Info

Publication number
ES2218796T3
ES2218796T3 ES98830310T ES98830310T ES2218796T3 ES 2218796 T3 ES2218796 T3 ES 2218796T3 ES 98830310 T ES98830310 T ES 98830310T ES 98830310 T ES98830310 T ES 98830310T ES 2218796 T3 ES2218796 T3 ES 2218796T3
Authority
ES
Spain
Prior art keywords
treatment
systemic
erimatus
lupus
peptidic compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98830310T
Other languages
English (en)
Inventor
Maria Marino
Maria Rossi
Giorgio Fassina
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tecnogen SpA
Original Assignee
Tecnogen SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tecnogen SpA filed Critical Tecnogen SpA
Application granted granted Critical
Publication of ES2218796T3 publication Critical patent/ES2218796T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE PRESENTA EL USO DE UN COMPUESTO PEPTIDICO DE LA FORMULA (I): (H 2 -N-X 1 -THR-X 2 -CO) N -R EN LA QUE X 1 , X 2 , N Y R TIENEN LOS SIGNIFICADOS RELACIONADOS EN LA DESCRIPCION PARA LA PREPARACION DE UNA COMPOSICION FARMACEUTICA UTIL EN EL TRATAMIENTO DEL LUPUS ERITHEMATOSUS SISTEMICO.
ES98830310T 1998-05-21 1998-05-21 Uso de un compuesto peptidico para el tratamiento del lupus erimatoso sistemico. Expired - Lifetime ES2218796T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98830310A EP0958829B1 (en) 1998-05-21 1998-05-21 Use of a peptide compound in the treatment of systemic lupus erythematosus

Publications (1)

Publication Number Publication Date
ES2218796T3 true ES2218796T3 (es) 2004-11-16

Family

ID=8236657

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98830310T Expired - Lifetime ES2218796T3 (es) 1998-05-21 1998-05-21 Uso de un compuesto peptidico para el tratamiento del lupus erimatoso sistemico.

Country Status (7)

Country Link
US (1) US6303577B1 (es)
EP (1) EP0958829B1 (es)
JP (1) JP2000053580A (es)
AT (1) ATE267018T1 (es)
CA (1) CA2270687A1 (es)
DE (1) DE69823981T2 (es)
ES (1) ES2218796T3 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100719202B1 (ko) 1998-10-23 2007-05-16 키린-암젠 인코포레이티드 ＭＰｌ 수용체에 결합하는 화합물 및 이를 함유하는 제약학적 조성물
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
US6916904B2 (en) 2002-04-24 2005-07-12 Zolaris Biosciences, Llc Inhibition of immune complex formation
US7442778B2 (en) 2004-09-24 2008-10-28 Amgen Inc. Modified Fc molecules
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
TW200827367A (en) 2006-10-26 2008-07-01 Kyowa Hakko Kogyo Kk A therapeutic agent for irritable bowel syndrome
EP3134732A2 (en) * 2014-04-24 2017-03-01 Alnylam Pharmaceuticals, Inc. Methods and compositions for detecting anti-drug antibodies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7525796A (en) * 1995-10-30 1997-05-22 Merck & Co., Inc. Novel inhibitors of peptide binding to mhc class ii proteins

Also Published As

Publication number Publication date
EP0958829B1 (en) 2004-05-19
US6303577B1 (en) 2001-10-16
CA2270687A1 (en) 1999-11-21
DE69823981D1 (de) 2004-06-24
JP2000053580A (ja) 2000-02-22
ATE267018T1 (de) 2004-06-15
DE69823981T2 (de) 2005-05-25
EP0958829A1 (en) 1999-11-24

Similar Documents

Publication Publication Date Title
UY34152A (es) ?oxazolidinonas substituidas y su uso?.
ES2524006T3 (es) Inhibición del crecimiento celular
DE60230340D1 (de) N-Ä4-(4-Amino-2-ethyl-1H-imidazoÄ4,5-cÜchinolin-1-yl)butylÜmethanesulfonamide, diese enthaltende pharmazeutische Zusammensetzung und deren Verwendung
BR0111520A (pt) Tiazina oxazolidinona usada como agente antimicrobiano
EA200100773A1 (ru) Замещенные 1-гетероциклические диариламины
PT1231918E (pt) Nova composicao e uso
DE69725825D1 (de) 5-HT1F-Agonisten
BR9909329A (pt) Método para estabilizar composições farmacêuticas pelo uso especial de um antioxidante
RU2001127848A (ru) Гетероциклические ароматические соединения, усиливающие секрецию гормона роста
TR199902655A2 (xx) K�k�rt-fonksiyonel poliorganosiloksanlar
TR200001012T2 (tr) Yeni ariloksi-alkil-dialkilaminler.
AR016981A2 (es) Polipeptidos sinteticos
IL173929A0 (en) Analogues of kahalalide f and pharmaceutical compositions containing the same
ATE240303T1 (de) 1,2,4-triazol-3-thion verbindungen
ES2218796T3 (es) Uso de un compuesto peptidico para el tratamiento del lupus erimatoso sistemico.
BR0004860B1 (pt) dispositivo para o condicionamento e a distribuição de uma composição e uso do dispositivo.
BG105539A (en) Eletriptan hydrobromide monohydrate
MX9707974A (es) Derivados de 10, 13, 15-trioxatriciclo [9.2.1.1 9.6]-pentadecanona, procedimientos para su preparacion y medicamentos que contienen estos compuestos.
BR0010317A (pt) Bandeja de armazenagem para refrigerador
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
DK1073447T3 (da) N1-modificerede glycopeptider
BR0112600A (pt) Compostos calcilìticos
EA200400670A1 (ru) Фармацевтические композиции, содержащие 3,4-пропинопергидропурины, и их применение для блокирования нейронной передачи
DE69725459D1 (de) Substituierte 1,2,3,4-tetrahydro-2-dibenzofuranamine und 2-aminocyclohepta(b)benzofurane
EP1059089A4 (en) DRUGS FOR PREVENTING / TREATING INFLAMMATORY BOWEL DISEASE